X0609 4 2024-08-12 0 0001533998 DarioHealth Corp. DRIO 0001668046 Raphael Erez false 322 W 57TH STREET, #33B NEW YORK NY 10019 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-08-12 4 C 0 579 19.1 A 157432 D Common Stock 2026-09-24 4 A 0 297000 0 A 454432 D Common Stock 1894 I By Dicilyon Consulting and Investment Ltd. Series B-2 Preferred Stock 1000 2024-08-12 4 C 0 30 1000 D 2023-05-04 2024-08-04 Common Stock 579 0 D Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date. The Reporting Person's 30 shares of Series B-2 Preferred Stock automatically converted into 11,574 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 579 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 157,432 shares of Common Stock immediately following the conversion. The restricted share award shall vest in eight equal quarterly installments on the last day of each successive calendar quarter after the grant date over a two-year period. /s/ Erez Raphael 2026-09-28